NICE's final appraisal indicates that Roche has offered the NHS a discount on the drug, which carrie...
Read moreIf the French government is able to deliver, pharmaceutical companies can look forward to potentiall...
Read moreCancer drug prices are rising rapidly, and profit margins for pharmaceutical companies reach upwards...
Read moreAs facilitators we can help companies understand what payer evidence is required to demonstrate the ...
Read moreThe collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read more13 market-changing drugs are expected to hit the European market this year and these blockbusters re...
Read moreMedicare would use a new International Pricing Index (IPI) model that considers international refere...
Read moreNICE has recently developed the META tool, to support MedTech manufacturers in the identification of...
Read moreOrphan drugs have important societal value as they improve patient quality of life and address unmet...
Read more